Litcius/Paper detail

Nanomedicine for Ischemic Stroke

Xinyue Dong, Jin Gao, Yujie Su, Zhenjia Wang

2020International Journal of Molecular Sciences90 citationsDOIOpen Access PDF

Abstract

Stroke is a severe brain disease leading to disability and death. Ischemic stroke dominates in stroke cases, and there are no effective therapies in clinic, partly due to the challenges in delivering therapeutics to ischemic sites in the brain. This review is focused on the current knowledge of pathogenesis in ischemic stroke, and its potential therapies and diagnosis. Furthermore, we present recent advances in developments of nanoparticle-based therapeutics for improved treatment of ischemic stroke using polymeric NPs, liposomes and cell-derived nanovesicles. We also address several critical questions in ischemic stroke, such as understanding how nanoparticles cross the blood brain barrier and developing in vivo imaging technologies to address this critical question. Finally, we discuss new opportunities in developing novel therapeutics by targeting activated brain endothelium and inflammatory neutrophils to improve the current therapies for ischemic stroke.

Topics & Concepts

MedicineStroke (engine)Ischemic strokeDiseaseNanomedicineBlood–brain barrierBrain ischemiaBioinformaticsNeuroscienceIntensive care medicineIschemiaInternal medicineNanotechnologyCentral nervous systemPsychologyNanoparticleBiologyMechanical engineeringMaterials scienceEngineeringNeuroinflammation and Neurodegeneration MechanismsAdvanced Nanomaterials in CatalysisS100 Proteins and Annexins
Nanomedicine for Ischemic Stroke | Litcius